Expanding the treatment arsenal in glaucoma management

Glaucoma remains a leading cause of irreversible blindness globally as progressive optic nerve damage leads to permanent vision loss. Recent advancements in glaucoma management—including novel mechanisms of action, innovative drug delivery systems, and minimally invasive glaucoma surgeries—may help improve adherence, efficacy, and outcomes.

This PER On Air Optometry Times podcast provides an in-depth review of some of the key highlights from the 18th Annual Controversies in Modern Eye Care Conference, held in May 2024. This unique and engaging multi-media activity focuses on the practical aspects of managing patients with glaucoma, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Inder Paul Singh, MD

President

The Eye Centers of Racine and Kenosha

Racine, WI

Deborah Ristvedt, DO

Anterior Segment Surgeon

Vance Thompson Vision

Alexandria, MN

Arsham Sheybani, MD

Associate Professor of Ophthalmology and Visual Sciences

Washington University School of Medicine in St Louis

St Louis, MO

Melissa Tawa, OD, FAAO

Assistant Professor

Jarnagin Center for Primary Eye Care and

Ocular Disease Service

University Eye Center at Ketchum Health

Marshall B. Ketchum University

Anaheim, CA